Literature DB >> 23519981

Nanomaterials and the human lung: what is known and what must be deciphered to realise their potential advantages?

Corinne Jud1, Martin J D Clift, Alke Petri-Fink, Barbara Rothen-Rutishauser.   

Abstract

Due to the constant expansion within the nanotechnology industry in the last decade, nanomaterials are omnipresent in society today. Nanotechnology-based products have numerous different applications ranging from electronic (e.g., advanced memory chips) to industrial (e.g., coatings or composites) to biomedical (e.g., drug delivery systems, diagnostics). Although these new nanomaterials can be found in many "everyday" products, their effects on the human body have still to be investigated in order to identify not only their risk, but also their potential benefits towards human health. Since the lung is commonly thought to be the main portal of entry into the human body for nanomaterials released within the environment, this review will attempt to summarise the current knowledge and understanding of how nanomaterials interact with the respiratory tract. Furthermore, the advantages and disadvantages of different experimental model systems that are commonly used to study this exposure route to the human body will be discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23519981     DOI: 10.4414/smw.2013.13758

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  9 in total

1.  MDSC and TGFβ Are Required for Facilitation of Tumor Growth in the Lungs of Mice Exposed to Carbon Nanotubes.

Authors:  Anna A Shvedova; Elena R Kisin; Naveena Yanamala; Alexey V Tkach; Dmitriy W Gutkin; Alexander Star; Galina V Shurin; Valerian E Kagan; Michael R Shurin
Journal:  Cancer Res       Date:  2015-03-05       Impact factor: 12.701

Review 2.  Gut-on-a-chip: Current progress and future opportunities.

Authors:  Nureddin Ashammakhi; Rohollah Nasiri; Natan Roberto de Barros; Peyton Tebon; Jai Thakor; Marcus Goudie; Amir Shamloo; Martin G Martin; Ali Khademhosseini
Journal:  Biomaterials       Date:  2020-06-14       Impact factor: 12.479

3.  Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model.

Authors:  Stefanie Grafmueller; Pius Manser; Liliane Diener; Pierre-André Diener; Xenia Maeder-Althaus; Lionel Maurizi; Wolfram Jochum; Harald F Krug; Tina Buerki-Thurnherr; Ursula von Mandach; Peter Wick
Journal:  Environ Health Perspect       Date:  2015-05-08       Impact factor: 9.031

4.  Comparative lung toxicity of engineered nanomaterials utilizing in vitro, ex vivo and in vivo approaches.

Authors:  Yong Ho Kim; Elizabeth Boykin; Tina Stevens; Katelyn Lavrich; M Ian Gilmour
Journal:  J Nanobiotechnology       Date:  2014-11-26       Impact factor: 10.435

Review 5.  Right or left: the role of nanoparticles in pulmonary diseases.

Authors:  Xuefei Lu; Tao Zhu; Chunying Chen; Ying Liu
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

6.  Engineering an in vitro air-blood barrier by 3D bioprinting.

Authors:  Lenke Horváth; Yuki Umehara; Corinne Jud; Fabian Blank; Alke Petri-Fink; Barbara Rothen-Rutishauser
Journal:  Sci Rep       Date:  2015-01-22       Impact factor: 4.379

7.  Advanced Respiratory Models for Hazard Assessment of Nanomaterials-Performance of Mono-, Co- and Tricultures.

Authors:  Laura Maria Azzurra Camassa; Elisabeth Elje; Espen Mariussen; Eleonora Marta Longhin; Maria Dusinska; Shan Zienolddiny-Narui; Elise Rundén-Pran
Journal:  Nanomaterials (Basel)       Date:  2022-07-29       Impact factor: 5.719

Review 8.  Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies.

Authors:  Eleonore Fröhlich; Sharareh Salar-Behzadi
Journal:  Int J Mol Sci       Date:  2014-03-18       Impact factor: 5.923

9.  Expert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials.

Authors:  Amy J Clippinger; Arti Ahluwalia; David Allen; James C Bonner; Warren Casey; Vincent Castranova; Raymond M David; Sabina Halappanavar; Jon A Hotchkiss; Annie M Jarabek; Monika Maier; William Polk; Barbara Rothen-Rutishauser; Christie M Sayes; Phil Sayre; Monita Sharma; Vicki Stone
Journal:  Arch Toxicol       Date:  2016-04-27       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.